Search by Drug Name or NDC

    NDC 71773-0050-05 Xerava 50 mg/1 Details

    Xerava 50 mg/1

    Xerava is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Tetraphase Pharmaceuticals, Inc.. The primary component is ERAVACYCLINE DIHYDROCHLORIDE.

    Product Information

    NDC 71773-0050
    Product ID 71773-050_6dae690a-73ae-42d2-a340-0d1c1f47fc13
    Associated GPIs 04300030102120
    GCN Sequence Number 078803
    GCN Sequence Number Description eravacycline di-hydrochloride VIAL 50 MG INTRAVEN
    HIC3 W1C
    HIC3 Description TETRACYCLINE ANTIBIOTICS
    GCN 45197
    HICL Sequence Number 045183
    HICL Sequence Number Description ERAVACYCLINE DI-HYDROCHLORIDE
    Brand/Generic Brand
    Proprietary Name Xerava
    Proprietary Name Suffix n/a
    Non-Proprietary Name eravacycline
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 50
    Active Ingredient Units mg/1
    Substance Name ERAVACYCLINE DIHYDROCHLORIDE
    Labeler Name Tetraphase Pharmaceuticals, Inc.
    Pharmaceutical Class Tetracycline-class Antibacterial [EPC], Tetracyclines [CS]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA211109
    Listing Certified Through 2024-12-31

    Package

    NDC 71773-0050-05 (71773005005)

    NDC Package Code 71773-050-05
    Billing NDC 71773005005
    Package 1 VIAL, GLASS in 1 CARTON (71773-050-05) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS
    Marketing Start Date 2018-09-10
    NDC Exclude Flag N
    Pricing Information N/A